PMID- 23295499 OWN - NLM STAT- MEDLINE DCOM- 20140505 LR - 20211021 IS - 1476-5497 (Electronic) IS - 0307-0565 (Print) IS - 0307-0565 (Linking) VI - 37 IP - 9 DP - 2013 Sep TI - Obesogenic phenotype of offspring of dams fed a high multivitamin diet is prevented by a post-weaning high multivitamin or high folate diet. PG - 1177-82 LID - 10.1038/ijo.2012.210 [doi] AB - BACKGROUND: High multivitamin (10-fold AIN-93G, HV) diets fed during pregnancy to Wistar rats increase characteristics of metabolic syndrome in offspring when weaned to the recommended vitamin (RV) diet. OBJECTIVE: To determine whether the effects of HV gestational diets on obesogenic phenotypes in the offspring arise as a consequence of altered hypothalamic control of feeding behavior and if their increased food intake could be prevented by feeding them HV or high folate (10-fold folate, HFol) diets. METHODS: Male offspring of dams fed HV diet during pregnancy weaned to RV, HV or HFol diets were compared with those born to RV dams and weaned to RV diet for 29 weeks. Food intake over 72 h and body weight were measured bi-weekly and weekly, respectively. Glucose response to a glucose load was measured at 18 weeks post weaning. Hypothalamic gene expression of feeding-related neuropeptides including neuropeptide Y, pro-opiomelanocortin (POMC), insulin receptor, leptin receptor, brain-derived neurotrophic factor (BDNF), receptors for dopamine (DopaR1/2/5) and serotonin (SeroR1A/2A/2C), as well as global DNA methylation and brain and plasma folate concentrations were measured at 29 weeks post weaning. RESULTS: HV or HFol pup diets increased brain and plasma folate concentrations and prevented the increase in food intake (5%, P=0.03), body weight (8%, P=0.0006) and glucose response to a glucose load (36%, P=0.02) found in those fed the RV diet. Expression of anorexigenic POMC (P=0.004) and BDNF (P=0.02) was higher, and DopaR1 was lower (P=0.06) in pups fed the HV diet. The HFol pup diet partially brought BDNF to the control level (P=0.02) and lowered SeroR2A (P=0.008). Expression of other genes was unaffected. Global DNA methylation was similar among the diet groups. CONCLUSION: The obesogenic phenotype in offspring from HV-fed dams is prevented by feeding HV or HFol pup diets, possibly due to post-weaning modulation of food intake regulatory mechanisms. FAU - Cho, C E AU - Cho CE AD - Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. FAU - Sanchez-Hernandez, D AU - Sanchez-Hernandez D FAU - Reza-Lopez, S A AU - Reza-Lopez SA FAU - Huot, P S P AU - Huot PS FAU - Kim, Y-I AU - Kim YI FAU - Anderson, G H AU - Anderson GH LA - eng GR - 93624-1/CAPMC/CIHR/Canada GR - MOP-93624/CAPMC/CIHR/Canada PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130108 PL - England TA - Int J Obes (Lond) JT - International journal of obesity (2005) JID - 101256108 RN - 0 (Biomarkers) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Receptors, Dopamine) RN - 0 (Receptors, Leptin) RN - 0 (Receptors, Serotonin) RN - 0 (Vitamins) RN - 66796-54-1 (Pro-Opiomelanocortin) RN - 7171WSG8A2 (BDNF protein, human) RN - 935E97BOY8 (Folic Acid) RN - EC 2.7.10.1 (Receptor, Insulin) SB - IM MH - Animals MH - Animals, Newborn MH - Biomarkers/metabolism MH - Body Weight MH - Brain-Derived Neurotrophic Factor/metabolism MH - Eating/*genetics MH - Feeding Behavior MH - Female MH - Folic Acid/administration & dosage/metabolism/*pharmacology MH - Gene Expression Regulation, Developmental MH - Hypothalamus/*metabolism MH - Male MH - Maternal Nutritional Physiological Phenomena/genetics MH - Metabolic Syndrome/etiology/genetics/*metabolism MH - Obesity/etiology/genetics/*metabolism MH - Phenotype MH - Pro-Opiomelanocortin/metabolism MH - Rats MH - Rats, Wistar MH - Receptor, Insulin/metabolism MH - Receptors, Dopamine/metabolism MH - Receptors, Leptin/metabolism MH - Receptors, Serotonin MH - Vitamins/administration & dosage/*pharmacology MH - Weaning PMC - PMC4954778 MID - CAMS4039 OID - NLM: CAMS4039 COIS- DISCLOSURE: The authors declare no conflict of interest. CONFLICT OF INTEREST The authors declare no conflict of interest. EDAT- 2013/01/09 06:00 MHDA- 2014/05/06 06:00 PMCR- 2016/07/20 CRDT- 2013/01/09 06:00 PHST- 2012/09/13 00:00 [received] PHST- 2012/10/31 00:00 [revised] PHST- 2012/11/18 00:00 [accepted] PHST- 2013/01/09 06:00 [entrez] PHST- 2013/01/09 06:00 [pubmed] PHST- 2014/05/06 06:00 [medline] PHST- 2016/07/20 00:00 [pmc-release] AID - ijo2012210 [pii] AID - 10.1038/ijo.2012.210 [doi] PST - ppublish SO - Int J Obes (Lond). 2013 Sep;37(9):1177-82. doi: 10.1038/ijo.2012.210. Epub 2013 Jan 8.